|
Looking Forward: Leadership in a Global Economy
Two events celebrating what is to come as we welcome a new CEO and hear thoughts and insights
about the global economy
October 14, 2009, San Francisco, CA
Dr. Jason Thomas, our Chief Investment Officer, leads a panel discussion about the
global economy featuring three highly regarded executives who are also clients of
Aspiriant. Themes of the discussion include industry and global trends, the
changing investment environment, managing a global workforce and strategies for
success in the future.
October 20, 2009, Los Angeles, CA
Dr. Jason Thomas, our Chief Investment Officer, participates in a
robust discussion with political commentator Greg Valliere on the current investment
and regulatory environment.
Past Client Events
Below are recordings of past conference calls with clients on the current economic and investment market environment.
Internet Explorer users: Please right click on the link and choose Save Target As...
Firefox users: Please right click on the link and choose Save Link As...
Client Conference Call – 2/27/2009
Client Conference Call – 12/02/2008
Client Conference Call – 10/14/2008
Greg Valliere Presentation – 09/18/2008
Aspiriant, LLC, is a registered investment advisor. Information presented in the conference call is not meant as a general guide to investing, or as a source of any specific investment recommendations and Aspiriant makes no implied or express recommendations concerning the manner in which any client’s or listener’s accounts should or would be handled, as appropriate investment decisions depend upon that party’s individual investment objectives. From time to time, Aspiriant provides conference calls for its clients and friends solely for educational and information purposes and that conference call is not intended to be an offer or solicitation, or the basis for any contract to purchase or sell any security or other instrument, for Aspiriant to enter into or arrange any type of transaction as a consequence of any information contained therein, and no offers or sales will be made in jurisdictions in which the offer and sale of such securities or other instruments is not qualified or otherwise exempt from regulation. Nothing discussed in the conference call should be interpreted to state or imply that past results are an indication of future performance. Although we believe the information in the conference call to be accurate, Aspiriant is not responsible for errors or other inaccuracies in the content of the conference call. Statements made by third party participants in the conference call do not necessarily reflect the opinions of Aspiriant and should not be construed as an endorsement by Aspiriant, either expressed or implied.
|